All Stories

  1. Emerging medical therapies for congenital adrenal hyperplasia

    Article • F1000Research, April 2019, Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  2. Response to Letter to the Editor: “Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline”

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2018, Endocrine Society

    Dr Phyllis W Speiser

  3. Demographics & Anthropometrics Impact Benefits of Health Intervention: Data from the ROAD Project

    Article • Obesity Science & Practice, November 2018, Wiley

    Dr Phyllis W Speiser

  4. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2018, Endocrine Society

    Dr Phyllis W Speiser

  5. Iatrogenic Cushing syndrome in a child with congenital adrenal hyperplasia: Erroneous compounding of hydrocortisone.

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2017, Endocrine Society

    Dr Phyllis W Speiser

  6. Androgenic Disorders and Abnormal Pubertal Development

    Article • January 2016, Springer Science + Business Media

    Dr Phyllis W Speiser

  7. Premature Ovarian Failure

    Article • January 2016, Springer Science + Business Media

    Dr Phyllis W Speiser

  8. Fetal Medical Therapy

    Article • November 2015, Wiley

    Dr Phyllis W Speiser

  9. Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR)

    Article • Pediatric Blood & Cancer, October 2015, Wiley

    Dr Phyllis W Speiser, Amit Lahoti

  10. Congenital Adrenal Hyperplasia

    Article • F1000Research, August 2015, Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  11. A Rationale for Mineralocorticoid Supplementation in Classic Congenital Adrenal Hyperplasia

    Article • Hormone Research in Paediatrics, January 2015, Karger Publishers

    Dr Phyllis W Speiser

  12. Pediatric endocrinologists' practices in screening for celiac disease in patients with type 1 diabetes

    Article • journal of Diabetes Research and Clinical Metabolism, January 2015, Herbert Publications PVT LTD

    Dr Phyllis W Speiser

  13. Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth

    Article • Journal of Diabetes, December 2014, Wiley

    Dr Phyllis W Speiser

  14. Faculty of 1000 evaluation for Relationship Between Final Height and Health Outcomes in Adults With Congenital Adrenal Hyperplasia: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE).

    Article • June 2014, Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  15. Debates and Controversies in Genetic Steroid Disorders

    Article • January 2014, Elsevier

    Dr Phyllis W Speiser

  16. Adrenal Incidentalomas

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2013, Endocrine Society

    Dr Phyllis W Speiser

  17. Racial/Ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in children

    Article • Obesity, July 2013, Wiley

    Dr Phyllis W Speiser

  18. Effects of parental origins and length of residency on adiposity measures and nutrition in urban middle school students: a cross-sectional study

    Article • International Journal of Pediatric Endocrinology, January 2013, Springer Science + Business Media

    Dr Phyllis W Speiser

  19. Testicular Adrenal Rests/Congenital Adrenal Hyperplasia

    Article • December 2012, Oxford University Press (OUP)

    Dr Phyllis W Speiser

  20. Congenital Adrenal Hyperplasia: Neuroendocrine, Behavioral and Cognitive Implications

    Article • November 2012, Springer Science + Business Media

    Dr Phyllis W Speiser

  21. Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children

    Article • Journal of Bone and Mineral Research, January 2012, Wiley

    Dr Phyllis W Speiser

  22. Treatment Outcomes in Congenital Adrenal Hyperplasia

    Article • Advances in Pediatrics, January 2012, Elsevier

    Dr Phyllis W Speiser

  23. Congenital Adrenal Hyperplasia

    Article • January 2012, Elsevier

    Dr Phyllis W Speiser

  24. JCEM ARCHIVECongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

    Article • September 2011, Endocrine Society

    Dr Phyllis W Speiser

  25. Congenital adrenal hyperplasia: an update in children

    Article • Current Opinion in Endocrinology Diabetes and Obesity, June 2011, Wolters Kluwer Health

    Dr Phyllis W Speiser

  26. The Reduce Obesity and Diabetes (ROAD) Project: Design and Methodological Considerations

    Article • Childhood Obesity, June 2011, Mary Ann Liebert Inc

    Dr Phyllis W Speiser

  27. Faculty of 1000 evaluation for A SEQUENCE VARIATION IN 3'UTR OF CYP21A2 GENE CORRELATES WITH A MILD FORM OF CONGENITAL ADRENAL HYPERPLASIA.

    Article • May 2011, Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  28. Medical Treatment of Classic and Nonclassic Congenital Adrenal Hyperplasia

    Article • January 2011, Springer Science + Business Media

    Dr Phyllis W Speiser

  29. Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2011, De Gruyter

    Dr Phyllis W Speiser

  30. Prenatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia

    Article • September 2010, Wiley

    Dr Phyllis W Speiser

  31. The Hormone Foundation’s Patient Guide to Congenital Adrenal Hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2010, Endocrine Society

    Dr Phyllis W Speiser

  32. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2010, Endocrine Society

    Dr Phyllis W Speiser

  33. Congenital Adrenal Hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2010, Endocrine Society

    Dr Phyllis W Speiser

  34. Hiperplasia suprarrenal congénita

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2010, Endocrine Society

    Dr Phyllis W Speiser

  35. Growth and development: Congenital adrenal hyperplasia—glucocorticoids and height

    Article • Nature Reviews Endocrinology, January 2010, Nature

    Dr Phyllis W Speiser

  36. A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency

    Article • International Journal of Pediatric Endocrinology, January 2010, Springer Science + Business Media

    Dr Phyllis W Speiser

  37. Novel P450c17 Mutation H373D Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2009, Endocrine Society

    Dr Phyllis W Speiser

  38. Managing Childhood Overweight: Behavior, Family, Pharmacology, and Bariatric Surgery Interventions

    Article • Obesity, March 2009, Wiley

    Dr Phyllis W Speiser

  39. Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2008, Endocrine Society

    Dr Phyllis W Speiser

  40. Mutations inProkineticin 2andProkineticin receptor 2genes in Human Gonadotrophin-Releasing Hormone Deficiency: Molecular Genetics and Clinical Spectrum

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2008, Endocrine Society

    Richard Quinton, Dr Phyllis W Speiser, Dr Andrew A Dwyer

  41. Nonclassic adrenal hyperplasia

    Article • Reviews in Endocrine and Metabolic Disorders, August 2008, Springer Science + Business Media

    Dr Phyllis W Speiser

  42. Prenatal and Neonatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia

    Article • Hormone Research in Paediatrics, January 2007, Karger Publishers

    Dr Phyllis W Speiser

  43. Diagnosis and management of congenital adrenal hyperplasia

    Article • Expert Review of Endocrinology & Metabolism, January 2006, Taylor & Francis

    Dr Phyllis W Speiser

  44. Childhood Obesity

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2005, Endocrine Society

    Dr Phyllis W Speiser, Dr Alan David Rogol

  45. The Genetics of Steroid 21-Hydroxylase Deficiency

    Article • The Endocrinologist, January 2005, Wolters Kluwer Health

    Dr Phyllis W Speiser

  46. Improving Neonatal Screening for Congenital Adrenal Hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2004, Endocrine Society

    Dr Phyllis W Speiser

  47. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee

    Article • The Journal of Pediatrics, October 2003, Elsevier

    Dr Phyllis W Speiser, Dr Alan David Rogol

  48. Congenital Adrenal Hyperplasia

    Article • New England Journal of Medicine, August 2003, New England Journal of Medicine (NEJM/MMS)

    Dr Phyllis W Speiser

  49. Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency

    Article • The Endocrinologist, July 2003, Wolters Kluwer Health

    Dr Phyllis W Speiser

  50. Authors’ Response: Regarding the Consensus Statement on 21-Hydroxylase Deficiency from the Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2003, Endocrine Society

    Dr Phyllis W Speiser

  51. Congenital Adrenal Hyperplasia

    Article • May 2003, Wiley

    Dr Phyllis W Speiser

  52. New therapies for congenital adrenal hyperplasia

    Article • Current Opinion in Endocrinology and Diabetes, February 2003, Wolters Kluwer Health

    Dr Phyllis W Speiser

  53. Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2002, Endocrine Society

    Dr Phyllis W Speiser

  54. Long-term consequences of childhood-onset congenital adrenal hyperplasia

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, June 2002, Elsevier

    Dr Phyllis W Speiser

  55. Continuous glucose monitoring in managing diabetes in children

    Article • Diabetes/Metabolism Research and Reviews, January 2002, Wiley

    Dr Phyllis W Speiser

  56. Congenital adrenal hyperplasia: Transition from childhood to adulthood

    Article • Journal of Endocrinological Investigation, October 2001, Springer Science + Business Media

    Dr Phyllis W Speiser

  57. PREFACE

    Article • Endocrinology and Metabolism Clinics of North America, March 2001, Elsevier

    Dr Phyllis W Speiser

  58. CONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY

    Article • Endocrinology and Metabolism Clinics of North America, March 2001, Elsevier

    Dr Phyllis W Speiser

  59. Molecular Diagnosis of CYP21 Mutations in Congenital Adrenal Hyperplasia

    Article • American Journal of PharmacoGenomics, January 2001, Springer Science + Business Media

    Dr Phyllis W Speiser

  60. 21-Hydroxylase–deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study

    Article • American Journal of Obstetrics and Gynecology, December 2000, Elsevier

    Berenice Mendonca, Dr Phyllis W Speiser, Professor Berenice B Mendonca

  61. Distinct Missense Mutations of the FGFR3 Lys650 Codon Modulate Receptor Kinase Activation and the Severity of the Skeletal Dysplasia Phenotype

    Article • The American Journal of Human Genetics, December 2000, Elsevier

    Dr Phyllis W Speiser

  62. A Multicenter Study of Women with Nonclassical Congenital Adrenal Hyperplasia: Relationship between Genotype and Phenotype

    Article • Molecular Genetics and Metabolism, November 2000, Elsevier

    Dr Phyllis W Speiser

  63. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency1

    Article • Endocrine Reviews, June 2000, Endocrine Society

    Dr Phyllis W Speiser

  64. Ovarian Hyperthecosis in the Setting of Portal Hypertension

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2000, Endocrine Society

    Dr Phyllis W Speiser

  65. Regulation of HSD17B1 and SRD5A1 in Lymphocytes

    Article • Molecular Genetics and Metabolism, November 1999, Elsevier

    Dr Phyllis W Speiser

  66. Toward better treatment of congenital adrenal hyperplasia*

    Article • Clinical Endocrinology, September 1999, Wiley

    Dr Phyllis W Speiser

  67. PRENATAL TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

    Article • The Journal of Urology, August 1999, Elsevier

    Dr Phyllis W Speiser

  68. PRENATAL TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

    Article • The Journal of Urology, August 1999, Elsevier

    Dr Phyllis W Speiser

  69. Genotyping CYP21 of Newborns for Congenital Adrenal Hyperplasia

    Article • Pediatric Research, April 1999, Nature

    Dr Phyllis W Speiser

  70. Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal Hyperplasia1

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1999, Endocrine Society

    Dr Phyllis W Speiser

  71. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency

    Article • Clinical Endocrinology, October 1998, Wiley

    Dr Phyllis W Speiser

  72. Study of a Kindred with Classic Congenital Adrenal Hyperplasia: Diagnostic Challenge due to Phenotypic Variance1

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1998, Endocrine Society

    Dr Phyllis W Speiser

  73. Prominent sex steroid metabolism in human lymphocytes

    Article • Molecular and Cellular Endocrinology, March 1998, Elsevier

    Dr Phyllis W Speiser

  74. Effects of androgens on gene expression in muscle 428

    Article • Pediatric Research, April 1997, Nature

    Dr Phyllis W Speiser

  75. Steroid 21-hydroxylase expression and activity in human lymphocytes

    Article • Molecular and Cellular Endocrinology, March 1997, Elsevier

    Dr Phyllis W Speiser

  76. ELEVATED URIC ACID LEVELS IN BLOOD FOLLOWING GROWTH HORMONE THERAPY.† 511

    Article • Pediatric Research, April 1996, Nature

    Dr Phyllis W Speiser

  77. Detection of Steroid 21-Hydroxylase Alleles Using Gene-Specific PCR and a Multiplexed Ligation Detection Reaction

    Article • Genomics, September 1995, Elsevier

    Dr Phyllis W Speiser

  78. Splicing mutation inCYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia

    Article • American Journal of Medical Genetics, July 1995, Wiley

    Dr Phyllis W Speiser

  79. Transient Central Precocious Puberty in Non-Classic 21-Hydroxylase Deficiency

    Article • Journal of Pediatric Endocrinology and Metabolism, January 1995, De Gruyter

    Dr Phyllis W Speiser

  80. Failure of Steroid Replacement to Consistently Normalize Pituitary Function in Congenital Adrenal Hyperplasia: Hormonal and MRI Data

    Article • Hormone Research, January 1995, Karger Publishers

    Dr Phyllis W Speiser

  81. The Genetics of 21-Hydroxylase Deficiency

    Article • The Endocrinologist, March 1994, Wolters Kluwer Health

    Dr Phyllis W Speiser

  82. Mutations in Steroid 21-Hydroxylase (CYP21)

    Article • Human Mutation, January 1994, Wiley

    Dr Phyllis W Speiser

  83. Molecular Genetic Prenatal Diagnosis of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency by Allele-Specific Hybridization

    Article • January 1994, Elsevier

    Dr Phyllis W Speiser

  84. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess

    Article • Metabolism, July 1993, Elsevier

    Dr Phyllis W Speiser

  85. INCREASED BONE MINERAL DENSITY IN CONGENITAL ADRENAL HYPERPLASIA (CAH)

    Article • Pediatric Research, May 1993, Nature

    Dr Phyllis W Speiser

  86. Congenital adrenal hyperplasia

    Article • Reproductive Medicine Review, March 1993, Cambridge University Press

    Dr Phyllis W Speiser

  87. Prenatal diagnosis/treatment in families at risk for infants with steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia)

    Article • The Journal of Steroid Biochemistry and Molecular Biology, March 1992, Elsevier

    Dr Phyllis W Speiser

  88. A Mutation (Pro-30 to Leu) inCYP21 Represents a Potential Nonclassic Steroid 21-Hydroxylase Deficiency Allele

    Article • Molecular Endocrinology, May 1991, Endocrine Society

    Dr Phyllis W Speiser

  89. Aldosterone Synthesis in Salt-Wasting Congenital Adrenal Hyperplasia with Complete Absence of Adrenal 21-Hydroxylase

    Article • New England Journal of Medicine, January 1991, New England Journal of Medicine (NEJM/MMS)

    Dr Phyllis W Speiser

  90. Bilateral Adrenal Uptake of Gallium-67 Citrate in a Patient with Congenital Adrenal Hyperplasia

    Article • Clinical Nuclear Medicine, November 1990, Wolters Kluwer Health

    Dr Phyllis W Speiser

  91. First Trimester Prenatal Treatment and Molecular Genetic Diagnosis of Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency)

    Article • Obstetrical & Gynecological Survey, October 1990, Wolters Kluwer Health

    Dr Phyllis W Speiser

  92. Prevalence of Nonclassical Steroid 21-Hydroxylase Deficiency Based on a Morning Salivary 17-hydroxyprogesterone Screening Test: A Small Sample Study*

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1990, Endocrine Society

    Dr Phyllis W Speiser

  93. First Trimester Prenatal Treatment and Molecular Genetic Diagnosis of Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency)*

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1990, Endocrine Society

    Dr Phyllis W Speiser

  94. Structure of the Human RD Gene: A Highly Conserved Gene in the Class III Region of the Major Histocompatibility Complex

    Article • DNA, December 1989, Mary Ann Liebert Inc

    Dr Phyllis W Speiser

  95. Molecular Genetic Analysis of Nonclassic Steroid 21 -Hydroxylase Deficiency Associated with HLA-B14, DRI

    Article • Obstetrical & Gynecological Survey, November 1988, Wolters Kluwer Health

    Dr Phyllis W Speiser

  96. Molecular Genetic Analysis of Nonclassic Steroid 21-Hydroxylase Deficiency Associated with HLA-B14,DR1

    Article • New England Journal of Medicine, July 1988, New England Journal of Medicine (NEJM/MMS)

    Dr Phyllis W Speiser

  97. ATYPICAL 11β-HYDROXYLASE DEFICIENCY: ABSENCE OF RENIN SUPPRESSION AND HYPERTENSION DESPITE HIGH DOC

    Article • Pediatric Research, April 1987, Nature

    Dr Phyllis W Speiser

  98. ACQUISITION OF ALDOSTERONE BIOSYNTHETIC CAPACITY IN CONGENITAL ADRENAL HYPERPLASIA WITH HOMOZYGOUS DELETION OF THE GENE ENCODING P450/C21

    Article • Pediatric Research, April 1987, Nature

    Dr Phyllis W Speiser

  99. Genotype and Hormonal Phenotype in Nonclassical 21-Hydroxylase Deficiency*

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1987, Endocrine Society

    Dr Phyllis W Speiser

  100. Genetics of Adrenal Steroid 21-Hydroxylase Deficiency*

    Article • Endocrine Reviews, August 1986, Endocrine Society

    Dr Phyllis W Speiser

  101. High Frequency of Nonclassical Steroid 21-Hydroxylase Deficiency

    Article • Obstetrical & Gynecological Survey, April 1986, Wolters Kluwer Health

    Dr Phyllis W Speiser

  102. Excess Mineralocorticoid Receptor Activity in Patients with Dexamethasone-Suppressible Hyperaldosteronism Is under Adrenocorticotropin Control*

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1985, Endocrine Society

    Dr Phyllis W Speiser

  103. Genetics of steroid 21-hydroxylase deficiency

    Article • Trends in Genetics, January 1985, Elsevier

    Dr Phyllis W Speiser

  104. Congenital Adrenal Hyperplasia

    Article • Springer Science + Business Media

    Dr Phyllis W Speiser

  105. Child with Rapid Growth and Precocious Sexual Maturation

    Article • Wiley

    Dr Phyllis W Speiser

  106. Faculty of 1000 evaluation for Newborn screening fact sheets.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  107. Faculty of 1000 evaluation for Reduced cortisol metabolism during critical illness.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  108. Faculty of 1000 evaluation for Congenital adrenal hyperplasia and the second newborn screen.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  109. Faculty of 1000 evaluation for Cortisol response to operative stress with anesthesia in healthy children.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  110. Faculty of 1000 evaluation for Central precocious puberty caused by mutations in the imprinted gene MKRN3.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  111. Faculty of 1000 evaluation for Nerve sparing ventral clitoroplasty preserves dorsal nerves in congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  112. Faculty of 1000 evaluation for False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  113. Faculty of 1000 evaluation for Presentation of primary adrenal insufficiency in childhood.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  114. Faculty of 1000 evaluation for Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  115. Faculty of 1000 evaluation for The effect of maternal vitamin d concentration on fetal bone.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  116. Faculty of 1000 evaluation for High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  117. Faculty of 1000 evaluation for Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  118. Faculty of 1000 evaluation for Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  119. Faculty of 1000 evaluation for Dexamethasone Induces Germ Cell Apoptosis in the Human Fetal Ovary.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  120. Faculty of 1000 evaluation for Dietary intervention in infancy and later signs of beta-cell autoimmunity.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  121. Faculty of 1000 evaluation for Neonatal screening for congenital adrenal hyperplasia in Japan.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  122. Faculty of 1000 evaluation for Approach to the patient: the adult with congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  123. Faculty of 1000 evaluation for Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  124. Faculty of 1000 evaluation for Glucocorticoids and foetal heart maturation; implications for prematurity and foetal programming.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  125. Faculty of 1000 evaluation for Generic levothyroxine compared with synthroid in young children with congenital hypothyroidism.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  126. Faculty of 1000 evaluation for A prospective study of testicular sperm extraction in young versus adult patients with non-mosaic 47,XXY Klinefelter syndrome. Preliminary results.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  127. Faculty of 1000 evaluation for Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  128. Faculty of 1000 evaluation for Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  129. Faculty of 1000 evaluation for Impact of Hydrocortisone on Adult Height in Congenital Adrenal Hyperplasia-The Minnesota Cohort.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  130. Faculty of 1000 evaluation for Growth hormone treatment for childhood short stature and risk of stroke in early adulthood.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  131. Faculty of 1000 evaluation for No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  132. Faculty of 1000 evaluation for Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  133. Faculty of 1000 evaluation for Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  134. Adrenal Hyperplasia, Congenital

    Article • Springer Science + Business Media

    Dr Phyllis W Speiser

  135. Adrenal Hyperplasia, Congenital (CAH)

    Article • Springer Science + Business Media

    Dr Phyllis W Speiser

  136. Congenital Adrenal Hyperplasia

    Article • Springer Science + Business Media

    Dr Phyllis W Speiser

  137. Faculty of 1000 evaluation for The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  138. Faculty of 1000 evaluation for Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  139. Faculty of 1000 evaluation for Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  140. Faculty of 1000 evaluation for Body fat and animal protein intakes are associated with adrenal androgen secretion in children.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  141. Faculty of 1000 evaluation for Transient Hypothyroidism at 3-Year Follow-Up among Cases of Congenital Hypothyroidism Detected by Newborn Screening.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  142. Faculty of 1000 evaluation for Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  143. Faculty of 1000 evaluation for Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  144. Faculty of 1000 evaluation for Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  145. Faculty of 1000 evaluation for Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  146. Faculty of 1000 evaluation for Final adult height in children with congenital adrenal hyperplasia treated with growth hormone.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  147. Faculty of 1000 evaluation for Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  148. Faculty of 1000 evaluation for Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  149. Faculty of 1000 evaluation for An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  150. Faculty of 1000 evaluation for Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  151. Faculty of 1000 evaluation for Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  152. Faculty of 1000 evaluation for Anti-mullerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  153. Faculty of 1000 evaluation for Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  154. Faculty of 1000 evaluation for Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  155. Faculty of 1000 evaluation for Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  156. Faculty of 1000 evaluation for In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  157. Faculty of 1000 evaluation for The effect of fetal androgen metabolism-related gene variants on external genitalia virilization in congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  158. Faculty of 1000 evaluation for Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  159. Faculty of 1000 evaluation for Anatomical and functional outcomes of feminizing genitoplasty for ambiguous genitalia in patients with virilizing congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  160. Faculty of 1000 evaluation for Role of 11βHSD Type 2 Enzyme Activity in Essential Hypertension and Children with Chronic Kidney Disease (CKD).

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  161. Faculty of 1000 evaluation for Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  162. Faculty of 1000 evaluation for Hormones, context, and "Brain Gender": A review of evidence from congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  163. Faculty of 1000 evaluation for Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  164. Faculty of 1000 evaluation for Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  165. Faculty of 1000 evaluation for Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  166. Faculty of 1000 evaluation for Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  167. Faculty of 1000 evaluation for A Phase 2 Study of Chronocort®, a Modified-release Formulation of Hydrocortisone, in the Treatment of Adults with Classic Congenital Adrenal Hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  168. Faculty of 1000 evaluation for One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  169. Faculty of 1000 evaluation for Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  170. Faculty of 1000 evaluation for A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  171. Faculty of 1000 evaluation for Prenatal Dexamethasone Treatment of Children at Risk for Congenital Adrenal Hyperplasia: The Swedish Experience and Standpoint.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  172. Faculty of 1000 evaluation for Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  173. Faculty of 1000 evaluation for Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  174. Faculty of 1000 evaluation for Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  175. Faculty of 1000 evaluation for Prenatal androgenization affects gender-related behavior but not gender identity in 5-12-year-old girls with congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  176. Faculty of 1000 evaluation for Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  177. Faculty of 1000 evaluation for Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  178. Faculty of 1000 evaluation for Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  179. Faculty of 1000 evaluation for Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  180. Faculty of 1000 evaluation for Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  181. Faculty of 1000 evaluation for Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  182. Faculty of 1000 evaluation for Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  183. Faculty of 1000 evaluation for Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  184. Faculty of 1000 evaluation for NIH working group report-using genomic information to guide weight management: From universal to precision treatment.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  185. Faculty of 1000 evaluation for NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  186. Faculty of 1000 evaluation for Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  187. Faculty of 1000 evaluation for New management strategy of pregnancies at risk of Congenital Adrenal Hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  188. Faculty of 1000 evaluation for Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results from the SEARCH for Diabetes in Youth.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  189. Faculty of 1000 evaluation for Testicular adrenal rest tumors develop independently of long-term disease control: A longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  190. Faculty of 1000 evaluation for The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  191. Faculty of 1000 evaluation for Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  192. Faculty of 1000 evaluation for Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser

  193. Faculty of 1000 evaluation for A TSHR-LH/CGR Chimera that Measures Functional Thyroid-Stimulating Autoantibodies (TSAb) Can Predict Remission or Recurrence in Graves' Patients Undergoing Antithyroid Drug (ATD) Treatment.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser, Amit Lahoti

  194. Faculty of 1000 evaluation for The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene.

    Article • Faculty of 1000, Ltd.

    Dr Phyllis W Speiser